177 related articles for article (PubMed ID: 37248978)
1. [Expert consensus on the clinical application of the markers of hepatitis B virus].
Cooperative Group of Basic Research and Experimental Diagnosis of Liver Diseases, Chinese Society of Hepatology, Chinese Medical Association
Zhonghua Gan Zang Bing Za Zhi; 2023 Apr; 31(4):389-400. PubMed ID: 37248978
[TBL] [Abstract][Full Text] [Related]
2. [Interpretation of the essential updates in guidelines for the prevention and treatment of chronic hepatitis B (Version 2022)].
You H; Sun YM; Zhang MY; Nan YM; Xu XY; Li TS; Wang GQ; Hou JL; Duan ZP; Wei L; Wang FS; Jia JD; Zhuang H
Zhonghua Gan Zang Bing Za Zhi; 2023 Apr; 31(4):385-388. PubMed ID: 37248977
[TBL] [Abstract][Full Text] [Related]
3. A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook.
Kramvis A; Chang KM; Dandri M; Farci P; Glebe D; Hu J; Janssen HLA; Lau DTY; Penicaud C; Pollicino T; Testoni B; Van Bömmel F; Andrisani O; Beumont-Mauviel M; Block TM; Chan HLY; Cloherty GA; Delaney WE; Geretti AM; Gehring A; Jackson K; Lenz O; Maini MK; Miller V; Protzer U; Yang JC; Yuen MF; Zoulim F; Revill PA
Nat Rev Gastroenterol Hepatol; 2022 Nov; 19(11):727-745. PubMed ID: 35859026
[TBL] [Abstract][Full Text] [Related]
4. New viral biomarkers for Hepatitis B: Are we able to change practice?
Höner Zu Siederdissen C; Maasoumy B; Cornberg M
J Viral Hepat; 2018 Nov; 25(11):1226-1235. PubMed ID: 30187603
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B core-related antigen: Are we near a treatment endpoint?
Gupta T
World J Gastroenterol; 2022 Jul; 28(27):3532-3534. PubMed ID: 36158266
[TBL] [Abstract][Full Text] [Related]
6. [Expanding antiviral therapy for chronic hepatitis B: scale up screening and treatment].
Zhang MY; Sun YM; You H
Zhonghua Gan Zang Bing Za Zhi; 2022 Nov; 30(11):1133-1136. PubMed ID: 36891686
[TBL] [Abstract][Full Text] [Related]
7. Advances in determining new treatments for hepatitis B infection by utilizing existing and novel biomarkers.
Mak LY; Hui RW; Cheung KS; Fung J; Seto WK; Yuen MF
Expert Opin Drug Discov; 2023 Apr; 18(4):401-416. PubMed ID: 36943183
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and treatment of chronic hepatitis B and D. Hungarian national consensus guideline].
Horváth G; Hunyady B; Gervain J; Lengyel G; Makara M; Pár A; Szalay F; Telegdy L; Tornai I
Orv Hetil; 2014 Mar; 155 Suppl():25-36. PubMed ID: 24631887
[TBL] [Abstract][Full Text] [Related]
9. [Research progress on clinical antiviral treatment of chronic hepatitis B in children].
; ; ;
Zhonghua Gan Zang Bing Za Zhi; 2024 May; 32(5):435-448. PubMed ID: 38858193
[TBL] [Abstract][Full Text] [Related]
10. Phyllanthus species versus antiviral drugs for chronic hepatitis B virus infection.
Xia Y; Luo H; Liu JP; Gluud C
Cochrane Database Syst Rev; 2013 Apr; (4):CD009004. PubMed ID: 23633363
[TBL] [Abstract][Full Text] [Related]
11. [Application of the new serum markers in the research and development of innovative hepatitis B drugs].
Lu FM; Wang J; Chen XM; Zhang XX; Zhang WH; Xu XY; Jia JD; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2020 Aug; 28(8):649-653. PubMed ID: 32911901
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis, diagnostic tests and monitoring of hepatitis B virus in monoinfected and HIV-coinfected patients.
Thio CL
Antivir Ther; 2007; 12 Suppl 3():H25-31. PubMed ID: 18284180
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and treatment of chronic hepatitis B and D. National consensus guideline in Hungary from 15 October 2016].
Horváth G; Gerlei Z; Gervain J; Lengyel G; Makara M; Pár A; Rókusz L; Szalay F; Tornai I; Werling K; Hunyady B
Orv Hetil; 2017 Feb; 158(Suppl 1):23-35. PubMed ID: 28218868
[TBL] [Abstract][Full Text] [Related]
14. Current view on hepatitis B diagnosis and therapy.
Husa P
Vnitr Lek; 2021; 67(1):48-50. PubMed ID: 33752391
[TBL] [Abstract][Full Text] [Related]
15. Taiwan consensus statement on the management of chronic hepatitis B.
Chien RN; Kao JH; Peng CY; Chen CH; Liu CJ; Huang YH; Hu TH; Yang HI; Lu SN; Ni YH; Chuang WL; Lee CM; Wu JC; Chen PJ; Liaw YF
J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):7-38. PubMed ID: 30527436
[TBL] [Abstract][Full Text] [Related]
16. How to interpret viral markers in the management of chronic hepatitis B infection.
Riveiro-Barciela M; Pericàs JM; Buti M
Clin Microbiol Infect; 2022 Mar; 28(3):355-361. PubMed ID: 34768018
[TBL] [Abstract][Full Text] [Related]
17. Prophylaxis, diagnosis and therapy of hepatitis B virus (HBV) infection: the German guidelines for the management of HBV infection.
Cornberg M; Protzer U; Dollinger MM; Petersen J; Wedemeyer H; Berg T; Jilg W; Erhardt A; Wirth S; Schirmacher P; Fleig WE; Manns MP
Z Gastroenterol; 2007 Dec; 45(12):1281-328. PubMed ID: 18080231
[No Abstract] [Full Text] [Related]
18. [Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011].
Cornberg M; Protzer U; Dollinger MM; Petersen J; Wedemeyer H; Berg T; Jilg W; Erhardt A; Wirth S; Schirmacher P; Fleig WE; Manns MP
Z Gastroenterol; 2007 Jun; 45(6):525-74. PubMed ID: 17554641
[No Abstract] [Full Text] [Related]
19. Management of acute hepatitis B and reactivation of hepatitis B.
Jindal A; Kumar M; Sarin SK
Liver Int; 2013 Feb; 33 Suppl 1():164-75. PubMed ID: 23286861
[TBL] [Abstract][Full Text] [Related]
20. Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers.
Liang LY; Wong VW; Wong GL; Yip TC
Clin Mol Hepatol; 2023 Jan; 29(1):113-117. PubMed ID: 36314042
[No Abstract] [Full Text] [Related]
[Next] [New Search]
